Allogeneic Stem Cell-Based Platforms to Potentiate & Deliver Oncolytic Virus Therapies

Time: 10:00 am
day: Day Two


• Protecting oncolytic viruses from inactivation by complement, blocking antibodies and innate immune cells

• Supporting oncolytic viral amplification inside the stem cells

• Modifying tumor microenvironment by inducing transient immune modulation suppression to allow effective tumor cell targeting and viral amplification at the tumor sites for an extended period